Previous 10 | Next 10 |
Halvorsen's 13F portfolio value increased from $27.68B to $36.37B. The number of positions increased from 86 to 96. Viking Global added UnitedHealth, AbCellera Biologics, Walt Disney, and Palo Alto Networks while dropping Analog Devices, CME Group, Comcast, and Exact Sciences. The...
Are These On The Top Of Your Penny Stocks Watch List Right Now? I get it; certain penny stocks are seeing some pressure. However, with as many that are under fire, there are plenty of others that have weathered the latest market volatility like pros. What’s been the differences? ...
aTyr Pharma, Inc. (LIFE) Q4 2020 Results Conference Call March 23, 2021 5:00 PM ET Company Participants Ashlee Dunston - Investor Relations Dr. Sanjay Shukla - President & CEO Jill Broadfoot - CFO Conference Call Participants Hartaj Singh - Oppenheimer Joseph Pantginis - H.C. Wainwright Z...
aTyr Pharma (LIFE): Q4 GAAP EPS of -$0.47 beats by $0.35.Revenue of $2.05M (+1364.3% Y/Y) beats by $1.92M.As of December 31, 2020, aTyr had $31.7 million in cash, cash equivalents and investments.The company expects its research and development expenses to increase in 2021 as it continues to ...
Completed enrollment of ATYR1923 clinical trial in patients with pulmonary sarcoidosis. Data is expected in the third quarter. Results from ATYR1923 clinical trial in patients with COVID-19 severe respiratory complications demonstrated favorable safety profile and signals of act...
San Diego, California--(Newsfile Corp. - March 19, 2021) - aTyr Pharma, Inc. (NASDAQ: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D., M.S., President and Chi...
The following slide deck was published by aTyr Pharma, Inc. in conjunction with this event. For further details see: aTyr Pharma (LIFE) Presents At H.C. Wainwright Global Life Sciences Conference - Slideshow
SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that it will report fourth quarter and full year 2020 financial resu...
LONDON, UK / ACCESSWIRE / March 16, 2021 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF) , one of the UK's leading CBD and Hemp product suppliers, is pleased to announce that it has secured an exclusive five year, multi-million-dollar global partnership Agreement (the "Agreement") with UFC (...
5 Names For Your Penny Stocks List We’re kick-starting another week where penny stocks are at the center of attention. While economic data could fuel broader markets, sentiment and momentum seem to be carrying things forward for small-cap stocks. Premarket trading in benchmark ET...
News, Short Squeeze, Breakout and More Instantly...
SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today ann...
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the c...
Independent data and safety monitoring board (DSMB) recommends continuation of study without any modifications. Findings further support favorable safety profile of efzofitimod. SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or the “Compa...